Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

Lethal several point mutations activates ZUP1. 1 / 1

| 1

➶

eidos

"On the other hand , the fact that the cis-cleavage activity is not required for PRRSV replication suggests that the lethal phenotype of several point mutations ( D85N , D85R , T88R , and D91R ) , which blocked both DUB and cis-activity , is not due to a block in cis-cleavage activity , but may be linked to the inactivation of PLP2 DUB activity ."

31561412

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...